Inherent interindividual and intraindividual variation in the length of the menstrual cycle limits the accuracy of predicting days of peak fertility. To improve detection of days of peak fertility, a more detailed understanding of longitudinal changes in cervicovaginal fluid (CVF) biomarkers during the normal menstrual cycle is needed. The aim of this study, therefore, was to characterize longitudinal changes in CVF proteins during the menstrual cycle using a quantitative, data-independent acquisition mass spectrometry approach. Six serial samples were collected from women (n ¼ 10) during the menstrual cycle. Samples were obtained at two time points for each phase of the cycle: early and late preovulatory, ovulatory, and postovulatory. Information-dependent acquisition (IDA) of mass spectra from all individual CVF samples was initially performed and identified 278 total proteins. Samples were then pooled by time of collection (n ¼ 6 pools) and analyzed using IDA and information-independent acquisition (Sequential Windowed Acquisition of All Theoretical Mass Spectra [SWATH]). The IDA library generated contained 176 statistically significant protein identifications (P , 0.000158). The variation in the relative abundance of CVF proteins across the menstrual cycle was established by comparison with the SWATH profile against the IDA library. Using time-series, pooled samples obtained from 10 women, quantitative data were obtained by SWATH analysis for 43 CVF proteins. Of these proteins, 28 displayed significant variation in relative abundance during the menstrual cycle (assessed by ANOVA). Statistical significant changes in the relative expression of CVF proteins during preovulatory, ovulatory, and postovulatory phases of menstrual cycle were identified. The data obtained may be of utility not only in elucidating underlying physiological mechanisms but also as clinically useful biomarkers of fertility status.
INTRODUCTION
Accurate prediction of the length and phases of the menstrual cycle is fundamental to the success of fertility awareness-based methods for the management of infertility and natural family planning [1] . The efficacy of fertility awarenessbased methods that rely on counting the days of the menstrual cycle, however, is affected by variability in cycle length, the timing of ovulation, and the window of peak fertility [2, 3] . For example, menstrual cycle length in normal healthy women varies from 21 to 35 days, and within individuals, maximum cycle length may vary by 6-11 days [4] . Cycle length is also affected by recent pregnancies or childbirth, breastfeeding, menarche or menopause, inherent cycle variation, or illness. The incidence of irregular cycles varies from 9% to 43% and is age related [3] . The window of fertility during the menstrual cycle spans from 5 days prior to ovulation to 1 day after ovulation [5] . Given these multiple sources of variation, the ability of women to successfully identify ovulation within the fertile period of the menstrual cycle is only ;55% and less than 30% on days of peak fertility. In addition, fertility awarenessbased methods, such as the rhythm method, require an accurate history of the menstrual cycles over the previous 8-12 mo to be considered reliable [6] . Even with such records they are associated with unplanned pregnancy rates of up to 18% [7] .
Cervicovaginal fluid (CVF) has been a valuable source of clinical information about the physiological and pathophysiological status of the female reproductive tract in both nonpregnant and pregnant women. Changes in the physical properties of cervical secretions are predictive of ovulation [8, 9] and monitoring such changes have been used successfully in fertility awareness-based methods, including the Billings ovulation method [10] and Creighton model [11] . As changes in the physiochemical composition of cervical secretions reflect underlying physiological processes, these methods are associated with lower rates of unplanned pregnancies. To improve the accuracy of such approaches to identify days of peak fertility requires a more detailed understanding of longitudinal (i.e., serial) changes in CVF biomarkers during the normal menstrual cycle. Currently, no such data are available. To date, menstrual phase-specific changes in CVF proteins and intersubject variability during the menstrual cycle remain to be established. In the absence of such baseline data, the physiological and pathophysiological significance of documenting CVF proteomes is unknown. Previous studies that utilized mass spectrometry (MS)-based approaches have only identified peptides and proteins and not applied quantitative methods. To date, most studies that have attempted to characterize CVF proteins have used samples obtained from pregnant and/or laboring women [12] [13] [14] or in association with cervical cancer [15] . Such samples would be expected to display very different proteomes than those obtained from nonpregnant women. Indeed, there is a paucity of data to establish any concordance between the quantitative expression of proteins in CVF obtained from nonpregnant and pregnant women.
The aim of this study, therefore, was to establish the quantitative and phase-specific expression of proteins present in CVF during the normal menstrual cycle (i.e., nonpregnant women). Two unique aspects of this study are the collection and analysis of serial (i.e., longitudinal) samples of CVF from individual women and the application of a quantitative MS profiling method (Sequential Windowed Acquisition of All Theoretical Mass Spectra [SWATH] ) to identify changes in protein abundance during the different phases (preovulatory, ovulatory, and postovulatory) of the menstrual cycle.
SWATH-MS is a data-independent acquisition method that systematically performs MS/MS in the mass range 350-1000 Da, repeatedly cycling in 25-Da increments over the entire chromatographic elution profile [16] . This generates a complete list of fragment ions and provides quantitative data of peptides peaks, identified in a preliminary informationdependent acquisition (IDA) run, to determine peptide charge and retention time information. Thus, this provides an unbiased quantitative tool to compare the relative abundance of targeted peptides and identified proteins in a sample. SWATH establishes a comprehensive and permanent digital record of the fragment ion spectra of all the analytes in a biological sample for which the precursor ions are within a predetermined m/z versus retention time window [17] and allows targeted extraction of quantitative data from the spectral libraries [17] [18] [19] [20] [21] [22] [23] . The application of both SWATH MS and Selected Reaction Monitoring (SRM) requires the a priori generation of reference spectral maps by IDA that provide spectral coordinates for quantification.
Herein, we demonstrate that the application of the mass spectrometric reference maps and the acquisition of SWATH maps to the analysis of human CVF holds promise for accelerating the process of biomarker discovery. In particular, the clinical significance of not only defining the CVF proteome but also quantifying phase-specific changes in protein abundance during the menstrual cycle resides in more accurate identification of female fertility status. Such data may be of utility in developing more effective multimarker in vitro diagnostics and point-of-care devices for the accurate and timely identification of periods of maximum fertility. Furthermore, the methods identified phase-specific CVF proteins not previously associated with the menstrual cycle. 
MATERIALS AND METHODS

Reagents
Study Design
The study design was a prospective cohort study ( Fig. 1 ) and was performed under ISO17025 requirements in a National Association of Testing Authorities (NATA)-accredited research facility. Serial samples of CVF were collected from the posterior fornix by the application of a sterile swab at speculum examination from 10 women at six time points during their menstrual cycles (with informed consent, and Human Research Ethics approval obtained from University Los Andes, Chile). Samples were collected from each woman at two time points during: the preovulatory (sample codes a and b, n ¼ 18, two missing samples); ovulatory (sample codes c and d, n ¼ 20) and postovulatory (sample codes e and f, n ¼ 20) phase of the menstrual cycle (Table 1) . Individual CVF samples (n ¼ 58) were reduced, alkylated, deglycosylated, trypsin digested, and subjected to standard liquid chromatography, tandem MS (IDA) analysis (experiment 1). Peptide ions were identified by database search strategies to define the CVF proteome obtained using the sample collection protocol.
To identify phase-specific changes in the abundance of CVF proteins during the menstrual cycle, samples were pooled by time of collection (n ¼ 6 pools) and subjected to liquid chromatography, tandem MS, and informationindependent acquisition (SWATH experiment 2). Six pooled samples (a, b, c, d, e, and f) of CVF were extracted and processed as three independent technical replicates (assay replicates). Each technical replicate was processed separately for IDA and SWATH data acquisition. The data obtained from each pool were combined to establish a sample-and study-specific peptide ion database (IDA library). The variation in the abundance of CVF peptides across the menstrual cycle was established by comparing SWATH peptide ion profiles against the IDA library using Peakview software.
CVF Collection
Healthy, nonpregnant, normally cycling women who were not taking a contraceptive pill were recruited to the study, with informed consent, from a natural family planning clinic at Hospital Parroquial de San Bernardo, San Bernardo, Chile (see Table 2 ). Serial samples of CVF were collected from individual healthy, infection-free, nonpregnant women (n ¼ 10) of reproductive age during the preovulatory, ovulatory, and postovulatory phases of the menstrual cycle. All CVF samples were collected in the absence of recent sexual activity (.24 h) per vagina at speculum examination by placing a sterile swab in the posterior fornix for 10 sec. The swab was removed and placed directly into a polypropylene tube and, within 10 min of collection, transported on ice and stored at À808C until extracted.
CVF Swab Extraction
Frozen swabs (swab tip downwards) were extracted in M-PER Mammalian Protein Extraction Reagent (500 ll) with no added protease inhibitors. Tubes were vortexed for 10 sec and then placed on a shaking platform (Thermo Fisher) at 200 rpm for 30 min at room temperature. Samples were incubated for 30 min at 48C and centrifuged for 15 min at 15 000 3 g at 48C (Heraeus Fresco21; Thermo Fisher). The swab was inverted in the tube (swab tip upwards) and then centrifuged at 15 000 3 g for 15 min at 48C. Supernatant fluid (;500 ll) was aspirated and used for further mass spectrometric processing and analysis. The remaining sample was stored at À808C.
CVF Protein Analysis
Total protein recovered from swab samples was determined using bicinchoninic acid assay and BSA as standard. Absorbance was measured at 562 nm using a microplate reader (BMG Labtech).
Reduction and Alkylation
Each sample was extracted in protein extraction reagent and prepared for MS analysis in triplicate (i.e., three independent technical replicates). Aliquots (100 ll, 1 lg protein/ll) of extracted swab supernatant fluid were mixed with ammonium bicarbonate (100 ll of 50 mM) for 10 sec on a vortex mixer. DTT/ bicarbonate (10 ll of 20 mM) was added to each sample and then incubated for 1 h at 608C. Iodoacetamide (10 ll of 1 M in 100 mM bicarbonate) was added to each tube and incubated for 1 h at 378C in the dark. Parallel incubations were performed using BSA (0.66 lg) as a quality control for reduction/alkylation and digestion reactions.
PNGase and Trypsin Treatment
Reduced and alkylated samples were deglycosylated by PNGase (4 ll, 200 units 10 ll of 53 MS reaction buffer), for 1 h at 378C. Samples were then VASWANI ET AL. digested with Trypsin Gold (1 lg) for 18 h at 378C. Postdigestion, formic acid (100 ll, 0.1%) was added and samples were centrifuged (15 000 3 g for 15 min) through 10-kDa-size exclusion membrane (Pall; Nanosep) [24] . The flowthrough fraction was retained for analysis.
Desalting
Peptides were desalted using a modified version of the stage tip protocol. Briefly, a 3-mm piece of an Empore C18 (Octadecyl) SPE Extraction Disk was excised and placed in a gel loader tip and POROS slurry (5 ll) was added to form a microcolumn [25] . Trifluoroacetic acid (1 volume, 0.1% in water) was added to the sample and loaded onto the microcolumn. The microcolumn was washed with trifluoroacetic acid (20 ll, 0.1% in water). Peptides were eluted from the microcolumn by three washes of acetonitrile (20 ll 3 3, 0.1% formic acid). Eluates were pooled and samples were dried at room temperature in a vacuum evaporator for 45 min. Samples were reconstituted in formic acid (50 ll, 0.1%), vortexed for 10 sec, and centrifuged for 2 min at 10 000 3 g to remove particulates.
Mass Spectrometry
Proteins present in CVF samples were identified by liquid chromatography, tandem MS (10 ll of reconstituted sample per injection, Eksigent 1D plus nanoflow, ultraperformance liquid chromatography system equipped with a Nanoflex cHiPLC Eksigent and a 5600 Triple TOF; AB Sciex). The cHiPLC was configured as a trap/column system. The trap dimensions were 200 lm internal diameter by 6 mm long, and it was packed with 3 lm 120-Å C18-CL ChromXP reversed-phase support. The column dimensions were 200 lm internal diameter by 15 cm long, and it was filled with the same material.
Peptides were separated using a linear gradient (60 min from 5% to 80% B at 500 nl/min) of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B) and were delivered by a Nanospray III electrospray interface (105 mm stainless steel emitter; THIES528; Thermo Fisher).
For standard information-dependent analysis, a 250-ms survey scan (timeof-flight MS) was collected, from which the top 25 ions were selected for automated MS/MS analysis in subsequent experiments where each MS/MS event consisted of a 100-ms scan. The selection criteria for parent ions included intensity (.150 counts/sec) and a charge state .2. Once an ion was fragmented by MS/MS, its mass and isotopes were excluded for a period of 6 sec. Ions were isolated using a quadrupole resolution of 0.7 Da and fragmented in the collision cell using collision energy ramped from 15 to 45 eV within the 100-ms accumulation time. In the instances where there were less than 25 parent ions PROFILING HUMAN CVF PROTEOME DURING MENSTRUAL CYCLE that met the selection criteria, ions were subjected to longer accumulation times to maintain a constant total cycle time of 1.25 sec. For SWATH MS-based experiments (experiment 2) the instrument was configured as described by Gillet et al. [26] . Briefly, the mass spectrometer was operated in a looped product ion mode. In this mode, the instrument was specifically tuned to allow a quadrupole resolution of 25 Da/mass selection. The stability of the mass selection was maintained by the operation of the radio frequency and direct current voltages on the isolation quadrupole in an independent manner. Using an isolation width of 26 Da (25 Da of optimal ion transmission efficiency, 1 Da for the window overlap), a set of 32 overlapping windows was constructed covering the mass range 400-1200 Da. Consecutive swaths need to be acquired with some precursor isolation window overlap to ensure the transfer of the complete isotopic pattern of any given precursor ion in at least one isolation window and thereby to maintain optimal correlation between parent and fragment isotopes peaks at any LC time point.
Data Analysis
To identify proteins present in individual CVF samples (experiment 1), mass spectra were analyzed using MASCOT and Protein Pilot search engines against the Swissprot database with the species set as human, specifying trypsin as the enzyme, one missed cleavage, and variable modifications were cysteines as carbamidomethyl and oxidized methionine. Significance of protein identification by IDA MS was ascribed using a Bonferroni correction for multiple hypothesis testing (i.e., 0.05/number of comparisons). Protein identifications that achieved significance and were identified in all three technical replicates were subjected to further statistical analyses (Mascot score cutoff was 38 or P , 0.000158).
The changes in the relative abundance of proteins present in CVF pools across the menstrual cycle were established by comparing the extracted-ion peak intensities of the three technical replicates for each sample (experiment 2; SWATH MS). Variation in the relative expression of proteins was assessed by two-way ANOVA with variance partitioned between sample collection time and protein. Where significance was established, group means were compared using post hoc test (corrected for multiple hypothesis testing, Bonferroni). Data are presented as mean 6 SEM (n ¼ 3). Ingenuity Pathway Analysis software was used to categorize CVF proteins identified into functional groups. Variation in the recovery of protein from swab samples was assessed by ANOVA (STAT 11; StataCorp LP), with the variance partitioned between menstrual cycle phase and subject. Data are presented as mean 6 SEM.
RESULTS
CVF Swab Protein Recovery
The overall recovery of protein from swabs averaged 1129 lg protein (mean 6 SEM, n ¼ 58, 2 missing values). Data were subjected to ANOVA with the variance partitioned between patients and phase of the cycle. No statistically significant effect was identified for either patient or phase of cycle (P . 0.38, n ¼ 58). The total protein recovered from preovulatory (a and b), ovulatory (c and d), and postovulatory (e and f) phase swabs averaged 1209 6 124, 1090 6 183 and 1090 6 90 lg protein, respectively. A swab control was used to demonstrate that no protein signatures were detected from an extracted blank swab (data not shown).
CVF Proteome
Experiment 1: standard LC MS/MS (IDA) of individual samples. A total of 278 CVF proteins were identified (Supplemental Table S1 ; Supplemental Data are available online at www.biolreprod.org). Of these, 176 CVF proteins were ascribed statistical significance (i.e., P , 0.000158, using a Bonferroni correction for multiple hypothesis testing; Supplemental Table S1 ).
Experiment 2: IDA SWATH method for pooled samples. IDA and SWATH profiles were generated for each pooled sample (n ¼ 6) in three independent technical replicates (i.e., independent sample processing). A combined IDA library was generated from the six individual IDA profiles (a, b, c, d, e, and f) using ProteinPilot. The IDA library was used to identify peptide ions that were present in SWATH ion profiles. Proteins were identified and quantified by comparing SWATHgenerated peptide ion profiles for each individual pool against the IDA library (PeakView). For example, the extracted-ion chromatograms for NEALIALLR (a peptide from plastin-2) at each phase of the three phases (preovulatory, ovulatory, and postovulatory) of the menstrual cycle are presented in Figure 2 . This figure shows how the intensity of the peptide ion changes across the three phases and the corresponding high-resolution product ion MS/MS spectrum. Here data from only three out of the six pools are represented in Figure 2 , namely A and D, pool a (early preovulatory phase); B and E, pool c (early ovulatory phase); and C and F, pool f (late postovulatory phase), where the figure clearly shows how intensity increases from a to c and c to f for the Plastin-2 peptide. Subsequently, only proteins that were identified in all three technical replicates of experiment 2 were included in subsequent quantitative analyses. All uncommon proteins between the three replicates were therefore eliminated.
Pathway Analyses
All the proteins identified in the study were categorized into pathways. A canonical pathway analysis of all the CVF proteins was generated using Ingenuity (Fig. 3) . This figure displays the top 25 pathways. Figure 4 presents the menstrual cycle variation in the relative abundance (mean 6 SEM, n ¼ 3) of proteins (n ¼ 43) that were identified in all three SWATH technical replicates. Twenty-eight proteins displayed significant changes in relative abundance across the menstrual cycle (as assessed by two-way ANOVA and Bonferroni post hoc tests). These proteins VASWANI ET AL.
included proteins previously associated with changes in the menstrual cycle, such as MMP9, defensins, and cystatin; hemoglobin and keratin isoforms were also identified. Other proteins are displayed in Supplemental Figure S1 .
DISCUSSION
CVF is composed of fluids that originate from the oviducts, endometrium, cervix, and vagina. The most important of these fluids is cervical mucus that regulates the overall viscosity of CVF. Ovarian steroids regulate changes in the secretion of cervical mucus throughout the menstrual cycle. During the ovulatory phase of the menstrual cycle the volume of CVF increases and is characterized by changes in water content, mucins, electrolytes, enzymes, and proteins [27] . Daily tracking of changes in the vulvar perception of CVF allows a woman to estimate her current phase of the menstrual cycle. Vulvar perception of CVF changes function as a fertility biomarker and is extensively used to establish daily fecundity [9, 11, 28] . Inherent interindividual and intraindividual variation in the length of the menstrual cycle, however, limits the accuracy of predicting days of peak fertility. In addition, some medical situations impair the assessment of CVF condition, including cervical ectropion or infection, ovarian cyst, vulvar dermatitis, and cervical surgery. Such cervical problems are also the cause of 5%-10% of cases of infertility PROFILING HUMAN CVF PROTEOME DURING MENSTRUAL CYCLE [29, 30] . Changes in cervical fluids may also influence sperm penetrability, nutrition, and survival.
Given these contributing factors, the ability to successfully identify ovulation within the fertile period of the menstrual cycle is only ;55%, and less that 30% on days of peak fertility. The identification of menstrual cycle phase-specific protein signatures, however, would represent an important clinical advance in assisting women to identify the presence of the fertility phase of the cycle and as a diagnostic aid to understand the etiology in some infertility cases or other gynecological diseases. To improve the detection of days of peak fertility, a more detailed understanding of longitudinal changes in CVF biomarkers during the normal menstrual cycle is needed.
Recent advances in MS data acquisition (such as SWATH MS) provide the opportunity to establish comprehensive digital reference libraries of peptides present in bio-specimens that can be used to identify and quantify the presence of constituent peptides in test samples [17, [19] [20] [21] . The aim of this study, therefore, was to utilize a SWATH MS method to profile proteins present in CVF collected longitudinally across the menstrual cycle. Swab samples of CVF were collected from normal, nonpregnant cycling women and analyzed by a traditional liquid chromatography MS approach and by SWATH. The reproducibility of sample collection was assessed by measuring total protein recovery and elution from swabs. The total CVF protein collected by swab application did not vary significantly across the menstrual cycle or between subjects.
Initially, using a liquid chromatography MS approach on individual CVF samples, 176 proteins were identified (only proteins that achieved statistical significance using a Bonferroni correction for multiple hypothesis testing are reported). These proteins were categorized into canonical pathways. The principal pathways represented included the LXR/RXR activation, FXR/RXR activation, acute phase response signaling, clathrin-mediated endocytosis signaling, and production of nitric oxide and reactive oxygen species pathways. Previous MS-based studies have identified a greater number of proteins present in CVF; for example, Shaw et al. [31] reported the identification of more than 600 CVF proteins. The difference in number of proteins identified most likely reflects different sampling techniques, site of collection, processing methods, and the attribution of statistical significance. In the study of Shaw et al. [31] , CVF was collected using a piece of gauze (5 3 5 cm) inserted into the vagina for 1 h. In this study, only posterior fornix fluid was collected. Where similar, more specific CVF collection methods have been used, a similar number of proteins were identified (e.g., Di Quinzio et al. [32] , 157 proteins; Dasari et al. [33] , 105 proteins; and Pereira et al. [34] , 205 proteins).
Although liquid chromatography MS is of utility in identifying CVF proteins, it is characterized by poor quantitation and reproducibility and biases to higher-abundance precursor-ion signals; thus, the fidelity for physiological timeseries comparisons may be compromised and low-abundance species may not be identified. In contrast, the alternative SWATH MS approach used in this study and applied to CVF Table S1 ). Protein identifications that achieved statistical significance (using a Bonferroni correction for multiple hypothesis testing, n ¼ 176) were categorized by canonical pathway analysis. Twenty-five canonical pathways were identified with Àlog(P value) less than 2.8 and containing two or more proteins per category.
VASWANI ET AL. PROFILING HUMAN CVF PROTEOME DURING MENSTRUAL CYCLE samples collected at six time points across the menstrual cycle is based upon information-independent acquisition. Using this approach, precursor ions are fragmented independently of their MS1 signal and a complete MS2 map is generated. The MS2 data are available for semantic analysis by comparison with a sample-specific spectra library (i.e., a list of peptide fragment masses generated at the same time). Quantitation is achieved by targeted data extraction using a list of fragment masses, and thus is similar to a multiple-SRM approach. Collins et al. [20] report the advantages of the SWATH as high throughput, accurate quantitation, and a wide dynamic range.
In this study, pooled samples were used for assessing changes in CVF protein relative abundance across the menstrual cycle. Similarly, previous studies have used pooled samples to build spectral libraries [21, 26] . As SWATH profiles exist for all proteins within the spectral library, variation in the abundance of the all proteins identified in the technical replicates across the menstrual cycle may be potentially evaluated (n ¼ 43; only proteins that were identified in all three independent replicate analyses are reported). Proteins that display phase-specific changes identified using the SWATH method included proteins previously implicated in menstrual cycle changes and pathologies (e.g., MMP9, defensins, cystatin, and hemoglobin isoforms). In addition, proteins not previously associated with menstrual physiology or pathophysiology were identified, including cornulin, plastin-2, CD69, BPI fold-containing family B member 1, and MELT (a plasma membrane protein, thought to be involved in phospholipid binding).
Cornulin is an S100 fused-type protein that is differentially expressed in cornifying keratinocytes of the epidermal layer of skin [35] . Its presence has been observed in the epithelia of the esophagus, within the inner root sheath of the hair follicles, and in the upper epidermis. Cornulin mRNA transcripts have been identified by quantitative PCR in other skin sites, such as scalp skin, foreskin, and cultured primary keratinocytes [36] , and the fetal brain, adult lung, uterus and kidney, skeletal muscle, and heart have also shown expression of this protein at a low level. Calcium-induced differentiation of keratinocytes has been linked to an increased expression of cornulin [36] . Other studies of the protein have further suggested that cornulin may be expressed in response to cellular homeostatic challenges and function as a survival factor [37] . It has been similarly proposed that cornulin may be a marker of late-stage epithelial cell differentiation. Interestingly, it has been noted that vaginal epithelial cells undergo hormone-dependent differentiation during the menstrual cycle that is associated with phasedependent expression of specific proteins, such as keratins [38] . Cornulin has been previously identified in vaginal secretions by MS; however, its precise role remains to be elucidated.
Members of the S100 family are small, calcium-binding proteins present in many cells. There are more than 20 different S100 proteins identified to date. They display differential tissue and cell-type expression profiles [39] . Apart from being involved in many intracellular processes in reaction to increases in intracellular calcium, there is now more focus on the extracellular functions of S100-family proteins. Of relevance to this study, S100s were shown to have antimicrobial functions and were capable of blocking bacterial propagation in mucosal epithelium. It has been reported that S100 proteins secreted from different cells during inflammation serve as useful markers of disease activity for a variety of indications, including chronic obstructive pulmonary disease, asthma, rheumatoid arthritis, colitis, Alzheimer disease, and cancer, among others, and may regulate inflammatory responses [39] . A subset of S100s, the calgranulins, specifically S100A8 (calgranulin A, MRP8), S100A9 (calgranulin B, MRP14) and S100A12 (calgranulin C, EN-RAGE) are present in neutrophils and monocytes and can be induced in endothelial and epithelial cells. S100A12 may induce cytokine expression and/or release. S100A8 and S100A9 are proinflammatory factors that induce chemotaxis of neutrophils and monocytes [39] . Infection-induced pathological inflammation causes chemotactic S100 proteins to be expressed by vaginal epithelial cells and present in vaginal secretions [40, 41] . Consistent with the data obtained in this study, Birse et al. [42] also identified an increased luteal-phase expression on S100-A12 in a crosssectional analysis of cervicovaginal lavage samples.
Plastin proteins are actin-bundling proteins [43] . L-plastin has been identified in hematopoietic linage cells [43] and implicated in the activation of T cells and the modulation of cell surface expression of IL2RA/CD25. L-plastin plays a role in innate and adaptive immunity [44] and is involved in NKG2D recruitment into lipid rafts and NKG2D-mediated NK cell migration [45] . The changes in L-plastin across the menstrual cycle may reflect changes in the number of leukocytes present. Interestingly, a study by Larsson and Platz-Christensen [46] on vaginal cells during the normal menstrual cycle reported a midcycle increase in the ratio of white blood cells to epithelial cells in posterior fornix. In this study, we identified unique L-plastin peptides in CVF (Supplemental Table S1 and Supplemental Figure S2 ) and an increase in their relative abundance during late phases of the menstrual cycle.
Another protein expressed in CVF proteome of normal menstrual cycle was CD69. This protein is an leukocytic early activation marker [47] . Interestingly, this protein, like Lplastin, has been found in circulating leukocytes and is present in intestinal mucosa, where it functions in an inflammatory role. It has been suggested to play a role in preventing bacterial pathogens from crossing the external layers of mucosa into the deeper inner tissues [47] . CD69 is expressed in memory T cells and regulatory T cells in intestinal tissue. Both L-plastin and CD-69 are important regulators of T-cell activation. Similar to L-plastin, CD69 may reflect the change in T-cells members during menstrual cycle. More research will need to be undertaken to determine if the expression of these two proteins correlates in the cervicovaginal environment.
Bactericidal permeability-increasing protein (BPI) is a 55-60-kDa cationic antimicrobial protein that is stored in primary azurophilic granula of neutrophil granulocytes and synthesized by mucosal epithelial cells. It is a member of a large family of lipid transfer proteins. Like CD69 and L-plastin, it may have an inflammatory role in the cervicovaginal environment. BPI is thought to neutralize the activity of LPS from Gram-negative bacteria by attaching to the LPS lipid A molecule on bacterial membranes; destroying the inner cell membrane and resulting in cell lysis [48] . Previously, antibacterial proteins have been identified in CVF, including defensins and cathelicidin [49, 50] , which we also identified in Supplemental Table S1 . BPI has not been previously identified in CVF. Elucidating the role of these proteins and their clinical utility is beyond the scope of this phase I biomarker study.
In conclusion, to date, definition of the CVF proteome has not adequately controlled for clinical factors such as biological variation (e.g., during the menstrual cycle) and the use of contraceptives [51] . In this study, CVF was obtained from VASWANI ET AL.
healthy, ovulatory, noncontraceptive women to establish a baseline proteomic profile. The identification of such profiles is the first step to create a gold standard to aid in the identification of abnormal and pathological conditions. The development of a sample processing method, including a small sample volume and application of SWATH MS to the longitudinal profiling of proteins present in CVF collected from the posterior fornix, affords opportunity for high-throughput, quantitative assessment of menstrual phase-specific changes. Such data may be of utility not only in elucidating underlying physiological mechanisms but also as clinically useful biomarkers of fertility status, the latter being of relevance in the context of family planning and the management of infertility.
